📋 Tender Overview
This inclusion represents a significant advance in Perus capacity to contribute to the research and diagnosis of infections by this virus. The National Reference Laboratory for Sexually Transmitted Viruses (LRN VTS) of the National Institute of Health (INS) of Peru has been officially incorporated into the Global Network of Reference Laboratories (LabNet) for human papillomavirus (HPV), led by the International Human Papillomavirus Reference Center (IHRC) of Sweden. This inclusion represents a significant advance in Perus capacity to contribute to the research and diagnosis of HPV infections, as well as in the fight against cervical cancer.
Since 2005, the IHRC has expanded its network of national reference laboratories, adding Peru as a new member. This Network, which already had laboratories from 12 countries, seeks to promote the standardization and quality of diagnostic services at an international level.
This incorporation into the Global LabNet, led by the IHRC, a WHO collaborating laboratory, will allow the INS LRN VTS to access resources, training in advanced cloning and purification technologies for plasmids through culture for the manufacture of proficiency panels, massive sequencing technologies for HPV virological surveillance, bioinformatics analysis and quality protocols, which will benefit the countrys public health.
In this regard, Dr. Joakim Dillner, director of the IHRC, has expressed his enthusiasm for the incorporation of new laboratories into the network this reinforces the global commitment to improve the detection and management of HPV.
It is important to note that the participation of the LRN VTS in this network will not only strengthen its technical capacity, but will also contribute to research and the implementation of effective strategies for the prevention of cervical cancer in Peru and the region.
This development is an important step towards improving public health and preventing HPV-associated diseases, thus reaffirming our countrys commitment to global health and international collaboration in the fight against cancer.
In Peru, according to figures provided by the Ministry of Health (Minsa), cervical cancer is the second cause of mortality among women in the country and in 2020, 4,270 new cases were reported, causing 2,288 deaths; that is, every day 12 women are diagnosed with cervical cancer and of these, 6 die.
